Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer - Macbeth, F; Griffiths, G; Noble, S; Burns, S; Maughan, T (2009)